Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial
de Alarcon, Pedro A, Matthay, Katherine K, London, Wendy B, Naranjo, Arlene, Tenney, Sheena C, Panzer, Jessica A, Hogarty, Michael D, Park, Julie R, Maris, John M, Cohn, Susan LLanguage:
english
Journal:
The Lancet Child & Adolescent Health
DOI:
10.1016/S2352-4642(17)30130-X
Date:
November, 2017
File:
PDF, 365 KB
english, 2017
File converter
More search results
More benefits 
